Skip to main content
Clinical Trials/CTRI/2012/07/002834
CTRI/2012/07/002834
Recruiting
N/A

The Role of Quantitative Sensory Testing in Asymptomatic Diabetic Neuropathy and its relationship with HbA1c.

A0 sites86 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
A
Enrollment
86
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 18 and above.
  • 2\. Diabetic patients who underwent Quantitative Sensory Testing (QST).

Exclusion Criteria

  • 1\. Patients with known vitamin B12 deficiency, chronic inflammatory polyneuropathy.
  • 2\. Patients taking neurotoxic drugs (cytotoxic drugs, isoniazid, metronidazole, chloramphenicol, nitrofurantoin, amiodarone, phenytoin, simvastatin).
  • 3\. Patients who present with heavy alcohol abuse (12\), \>\=75 g daily.
  • 4\. Patients with known vasculitis.
  • 5\. Patients with known heavy metal poisoning.
  • 6\. Patients suffering from cancer or on chemotherapy.
  • 7\. Patients with severe chronic kidney disease based on clinical findings.

Outcomes

Primary Outcomes

Not specified

Similar Trials